Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer - The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29).
| Image |  |
|---|---|
| Description | scientific article published on 17 June 2016 |
| Author/s |
author: Andreas Schneeweiss Michael Untch Sibylle Loibl Carsten Denkert Peter A. Fasching |
| Publication date | June 17, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |